Jim Rauh departs from Golden Gate Capital

While at Golden Gate, the managing director was involved with recent investments including Cole-Parmer, which makes laboratory and industrial-fluid-handling products, instrumentation, equipment and supplies.

Jim Rauh has left Golden Gate Capital as a managing director after more than a decade at the San Francisco private equity firm, PE Hub has learned.

Rauh, who joined Golden Gate in 2009, focused on investments in the broader industrials sector with an emphasis on healthcare and packaging. The investor’s future plans are unclear.  

Before joining Golden Gate, Rauh was on the investment team at New York private equity firm JLL Partners.  

While at Golden Gate, Rauh was involved with recent investments including Cole-Parmer, which makes laboratory and industrial-fluid-handling products, instrumentation, equipment and supplies. Golden Gate bought Cole-Parmer from GTCR in mid-2017, selling a majority stake back to GTCR in a $2 billion-plus deal last fall, sources told PE Hub at that time. 

Golden Gate’s remaining team members focused on the the broader industrials sector include managing directors Felix Lo, Dave Thomas and Bob Kirby. 

The firm a couple years ago lost Rajeev Amara, who founded and previously led Golden Gate’s industrials vertical. Amara, who left after 18 years at Golden Gate, raised $1.5 billion for his new firm, Arcline Investment Management, in March 2019.

Golden Gate earlier this week sold a 50 percent stake in ANGUS Chemical to Ardian for a total enterprise value of $2.25 billion. The firm plans to retain the remaining 50 percent stake. In August, Golden Gate divested its remaining Red Lobster stake to Thai Union. 

Golden Gate declined to comment.

Action Item: Read more about Golden Gate’s partial sale of ANGUS.